Richardson / Warnock | Fungal Infection 4e | Buch | 978-1-4051-7056-7 | sack.de

Buch, Englisch, 476 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 689 g

Richardson / Warnock

Fungal Infection 4e


4th Auflage
ISBN: 978-1-4051-7056-7
Verlag: Wiley

Buch, Englisch, 476 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 689 g

ISBN: 978-1-4051-7056-7
Verlag: Wiley


Fungal Infection: Diagnosis and Management, 4th Edition is a concise and up-to-date guide to the clinical manifestations, laboratory diagnosis and management of superficial, subcutaneous and systemic fungal infections.

This highly acclaimed book has been extensively revised and updated throughout to ensure all drug and dosage recommendations are accurate and in agreement with current guidelines. A new chapter on infections caused by Pneumocystis jirovecii has been added. The book has been designed to enable rapid information retrieval and to help clinicians make informed decisions about diagnosis and patient management. Each chapter concludes with a list of recent key publications which have been carefully selected to facilitate efficient access to further information on specific aspects of fungal infections.

Clinical microbiologists, infectious disease specialists, as well as dermatologists, hematologists and oncologists, can depend on this contemporary text for authoritative information and the background necessary to understand fungal infections.

Richardson / Warnock Fungal Infection 4e jetzt bestellen!

Weitere Infos & Material


Preface to the fourth edition, xxvi

Preface to the first edition, xxviii

Acknowledgements, xxix

1 Introduction, 1

1.1 The nature of fungi, 1

1.2 Classification and nomenclature of fungi and fungal diseases, 3

1.3 Fungi as human pathogens, 5

1.4 The changing pattern of fungal infection, 7

1.5 New directions in diagnosis, 9

1.6 New directions in treatment and prevention, 10

2 Laboratory diagnosis of fungal infection, 12

2.1 Introduction, 12

2.2 Collection of specimens, 13

2.3 Specimens for serological tests, 18

2.4 Specimens for antifungal drug level determinations, 18

2.5 Transport of specimens, 18

2.6 Interpretation of laboratory test results, 18

2.7 Molecular diagnosis of fungal infection, 28

3 Antifungal drugs, 32

3.1 Introduction, 32

3.2 Allylamines, 32

3.4 Other allylamine compounds for topical administration, 35

3.5 Azoles, 35

3.6 Fluconazole, 40

3.7 Itraconazole, 44

3.8 Ketoconazole, 48

3.9 Posaconazole, 50

3.10 Voriconazole, 53

3.11 Other imidazole compounds for topical administration, 57

3.12 Echinocandins, 59

3.13 Anidulafungin, 60

3.14 Caspofungin, 61

3.15 Micafungin, 63

3.16 Polyenes, 65

3.17 Amphotericin B, 66

3.18 Other polyene compounds for topical administration, 76

3.19 Flucytosine, 76

3.20 Griseofulvin, 79

3.21 Other miscellaneous compounds for topical administration, 81

3.22 Prophylactic treatment for prevention of fungal infection, 82

3.23 Empirical treatment of suspected fungal infection in the neutropenic patient, 84

3.24 Pre-emptive antifungal treatment, 85

3.25 Combination antifungal treatment of invasive fungal infections, 85

3.26 Laboratory monitoring, 86

4 Dermatophytosis, 91

4.1 Introduction, 91

4.2 The causal organisms and their habitat, 92

4.3 Epidemiology, 93

4.4 Laboratory diagnosis of dermatophytosis, 94

4.5 Tinea capitis, 95

4.6 Tinea corporis, 102

4.7 Tinea cruris, 105

4.8 Tinea pedis, 107

4.9 Tinea manuum, 111

4.10 Tinea unguium, 113

5 Superficial candidosis, 121

5.1 Definition, 121

5.2 Geographical distribution, 121

5.3 The causal organisms and their habitat, 121

5.4 Epidemiology, 122

5.5 Clinical manifestations, 124

5.6 Essential investigations and their interpretation, 130

5.7 Management, 130

5.8 Prevention, 136

6 Other cutaneous fungal infections, 138

6.1 Pityriasis versicolor, 138

6.2 Other Malassezia infections, 142

6.3 Piedra, 143

6.4 White piedra, 144

6.5 Black piedra, 145

6.6 Tinea nigra, 147

6.7 Neoscytalidium infection, 148

6.8 Alternaria infection, 149

7 Mould infections of nails, 151

7.1 Definition, 151

7.2 Geographical distribution, 151

7.3 The causal organisms and their habitat, 151

7.4 Epidemiology, 152

7.5 Clinical manifestations, 152

7.6 Differential diagnosis, 153

7.7 Essential investigations and their interpretation, 153

7.8 Management, 154

7.9 Prevention, 155

8 Keratomycosis, 156

8.1 Definition, 156

8.2 Geographical distribution, 156

8.3 The causal organisms and their habitat, 156

8.4 Epidemiology, 157

8.5 Clinical manifestations, 158

8.6 Essential investigations and their interpretation, 159

8.7 Management, 160

9 Otomycosis, 162

9.1 Definition, 162

9.2 Geographical distribution, 162

9.3 The causal organisms and their habitat, 162

9.4 Epidemiology, 162

9.5 Clinical manifestations, 163

9.6 Differential diagnosis, 164

9.7 Essential investigations and their interpretation, 164

9.8 Management, 164

10 Aspergillosis, 166

10.1 Definition, 166

10.2 Geographical distribution, 166

10.3 The causal organisms and their habitat, 166

10.4 Epidemiology, 167

10.5 Clinical manifestations, 170

10.6 Essential investigations and their interpretation, 182

10.7 Management, 186

10.8 Empirical treatment of suspected invasive aspergillosis, 194

10.9 Prevention, 195

11 Invas


Malcolm D. Richardson, PhD, FIBiol, FRCPath, Associate Professor in Medical Mycology and General Secretary, International Society for Human and Animal Mycology; Mycology Unit, Department of Bacteriology and Immunology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland and Associate Editor, Journal of Medical Microbiology.

David W. Warnock, PhD, FRCPath, Director of the Division of Bacterial and Mycotic Disease, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.



Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.